Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
6,570.00
+90.00 (1.39%)
At close: Oct 2, 2025
Seoulin Bioscience Market Cap
Seoulin Bioscience has a market cap or net worth of 56.16 billion as of October 10, 2025. Its market cap has decreased by -12.32% in one year.
Market Cap
56.16B
Enterprise Value
38.48B
Revenue
71.00B
Ranking
n/a
PE Ratio
35.34
Stock Price
6,570.00
Market Cap Chart
Since October 25, 2005, Seoulin Bioscience's market cap has decreased from 69.74B to 56.16B, a decrease of -19.48%. That is a compound annual growth rate of -1.08%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 10, 2025 | 56.16B | -8.62% |
Dec 30, 2024 | 61.46B | -21.97% |
Dec 28, 2023 | 78.77B | -19.25% |
Dec 29, 2022 | 97.55B | -44.18% |
Dec 30, 2021 | 174.75B | 62.58% |
Dec 30, 2020 | 107.49B | 56.83% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 579.68T |
SK hynix | 273.06T |
LG Energy Solution | 93.37T |
Samsung Biologics | 71.81T |
Hanwha Aerospace | 56.44T |
Hyundai Motor Company | 48.05T |
HD Hyundai Heavy Industries | 46.87T |
KB Financial Group | 42.53T |